You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Leptomeningeal disease

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Meningeal Tumors, Leptomeningeal Disease Trial in Tübingen (No intervention)

Not yet recruiting
  • Meningeal Neoplasms
  • Leptomeningeal Disease
  • No intervention
  • Tübingen, Germany
    University Hospital Tübingen, Neurooncology
Nov 16, 2023

HER2-positive Breast Cancer, Leptomeningeal Metastasis, Leptomeningeal Disease Trial in Tampa, Evanston (Radiation Therapy,

Recruiting
  • HER2-positive Breast Cancer
  • +2 more
  • Radiation Therapy
  • +2 more
  • Tampa, Florida
  • +1 more
Dec 30, 2022

Leptomeningeal Metastases, Leptomeningeal Disease Trial in Tampa (Avelumab, Whole Brain Radiotherapy)

Active, not recruiting
  • Leptomeningeal Metastases
  • Leptomeningeal Disease
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Aug 19, 2022

Leptomeningeal Disease Trial in Germany (Nivolumab [Opdivo])

Recruiting
  • Leptomeningeal Disease
  • Nivolumab [Opdivo]
  • Freiburg, Germany
  • +6 more
Nov 2, 2022

Metastatic Breast Cancer, Advanced Non-Small Cell Squamous Lung Cancer, Solid Tumor, Adult Trial (Patritumab deruxtecan)

Not yet recruiting
  • Metastatic Breast Cancer
  • +2 more
  • Patritumab deruxtecan
  • (no location specified)
May 9, 2023

Leptomeningeal Disease, Triple Negative Breast Cancer, HER2-positive Breast Cancer Trial in Tampa (Dendritic Cell Vaccine)

Recruiting
  • Leptomeningeal Disease
  • +2 more
  • Dendritic Cell Vaccine
  • Tampa, Florida
    Moffitt Cancer Center
Apr 11, 2023

Patients With Leptomeningeal Metastases ((LM) Using CNSide

Recruiting
  • Leptomeningeal Metastasis
  • +4 more
  • CNSide
  • Los Angeles, California
    Valkyrie Clinical Trials
Sep 7, 2022

Acral Lentiginous Melanoma, CNS Melanoma, Clinical Stage IV Cutaneous Melanoma AJCC v8 Trial in Houston (Nivolumab)

Active, not recruiting
  • Acral Lentiginous Melanoma
  • +9 more
  • Biospecimen Collection
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 31, 2023

HER2-positive Breast Cancer, LMD Trial (Tucatinib 150 MG, Trastuzumab, Capecitabine)

Not yet recruiting
  • HER2-positive Breast Cancer
  • LMD
  • Tucatinib 150 MG
  • +3 more
  • (no location specified)
Aug 24, 2023

Metastatic Breast Cancer, Leptomeningeal Disease Trial in Baltimore, Saint Louis, Winston-Salem (High-dose Methotrexate (8

Recruiting
  • Metastatic Breast Cancer
  • Leptomeningeal Disease
  • High-dose Methotrexate (8 gm/m2; HD-MTX)
  • Baltimore, Maryland
  • +2 more
May 5, 2022

Breast Carcinoma, Metastatic Malignant Tumor in the Brain, Metastatic Malignant Tumor in the Leptomeninges Trial in Chicago

Not yet recruiting
  • Breast Carcinoma
  • +2 more
  • Biospecimen Collection
  • +6 more
  • Chicago, Illinois
    Northwestern University
Nov 14, 2023

Patients With Leptomeningeal Disease Trial in Baltimore (Pembrolizumab)

Terminated
Has Results
  • Patients With Leptomeningeal Disease
  • Baltimore, Maryland
    Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Jan 6, 2021

Glioblastoma, Glioblastoma Multiforme, Glioma, Malignant Trial in Jyväskylä, Oulu, New Delhi (EGFRvIII-specific hinge-optimized

Active, not recruiting
  • Glioblastoma
  • +2 more
  • EGFRvIII-specific hinge-optimized CD3 ζ-stimulatory/41BB-co-stimulatory Chimeric Antigen Receptor autologous T-lymphocytes
  • Jyväskylä, Finland
  • +2 more
Sep 30, 2021

Metastatic Breast Cancer, Leptomeningeal Disease Trial in United States (Tucatinib, Trastuzumab, Capecitabine)

Active, not recruiting
  • Metastatic Breast Cancer
  • Leptomeningeal Disease
  • Birmingham, Alabama
  • +8 more
Oct 12, 2021

Recurrent Glioblastoma Multiforme, Primary Glioblastoma Multiforme, Brain Tumors, Malignant Trial in United Kingdom, United

Recruiting
  • Recurrent Glioblastoma Multiforme
  • +3 more
  • Boston, Massachusetts
  • +8 more
Jul 15, 2022

Brain and CNS Tumors, Chronic Myeloproliferative Disorders, Leukemia Trial in Chicago (Pemetrexed)

Completed
  • Brain and Central Nervous System Tumors
  • +10 more
  • Chicago, Illinois
    Robert H. Lurie Comprehensive Cancer Center at Northwestern Univ
Sep 3, 2021

Brain Metastases, Adult Trial in Switzerland (preoperative radiosurgery, postoperative hypofractionated stereotactic

Recruiting
  • Brain Metastases, Adult
  • preoperative radiosurgery
  • postoperative hypofractionated stereotactic radiotherapy
  • Aarau, Aargau, Switzerland
  • +5 more
Sep 7, 2022

NSCLC Associated With Leptomeningeal Metastases Trial (Tislelizumab, pemetrexed)

Not yet recruiting
  • NSCLC Associated With Leptomeningeal Metastases
  • Tislelizumab, pemetrexed
  • (no location specified)
Nov 21, 2023

NSCLC Trial in Chongqing (Aumonertinib 165mg orally once daily and intrathecal chemo with pemetrexed)

Recruiting
  • Non-small Cell Lung Cancer
  • Aumonertinib 165mg orally once daily and intrathecal chemotherapy with pemetrexed
  • Chongqing, China
    chongqing University Three Gorges Hospital
Apr 11, 2023

Ependymoma, Glioblastoma, Medulloblastoma Trial in Duarte (IL13Ralpha2-specific Hinge-optimized 41BB-co-stimulatory CAR

Recruiting
  • Ependymoma
  • +3 more
  • IL13Ralpha2-specific Hinge-optimized 41BB-co-stimulatory CAR Truncated CD19-expressing Autologous T-Lymphocytes
  • Duarte, California
    City of Hope Medical Center
Mar 9, 2022

NSCLC, Epidermal Growth Factor Receptor, Leptomeningeal Metastasis Trial (Pemetrexed)

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • +2 more
  • (no location specified)
Mar 27, 2023

Breast Cancer Metastatic, Leptomeningeal Metastasis Trial (Tucatinib Oral Tablet, Capecitabine tablets, Trastuzumab Injection)

Not yet recruiting
  • Breast Cancer Metastatic
  • Leptomeningeal Metastasis
  • Tucatinib Oral Tablet
  • +2 more
  • (no location specified)
Mar 23, 2023

Non Small Cell Lung Cancer Trial in Hangzhou (Furmonertinib Mesilate Tablets)

Enrolling by invitation
  • Non Small Cell Lung Cancer
  • Furmonertinib Mesilate Tablets
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital, College of Medicine, Zhejiang Uni
Apr 3, 2023

Leptomeningeal Metastasis Trial in Changchun (Pemetrexed, Radiotherapy)

Recruiting
  • Leptomeningeal Metastasis
  • Changchun, Jilin, China
    The First Hospital of Jilin University
Jun 8, 2022

Breast Cancer Trial (Consultation, Cerebral and medullary MRI, lumbar puncture, CSF sampling, biological test)

Not yet recruiting
  • Breast Cancer
  • Consultation
  • +2 more
  • (no location specified)
Nov 28, 2022